Iron chelation
Deferiprone and other iron chelators tested for slowing nigral degeneration (FAIRPARK-II and successors).
State of the art
No update yet for Iron chelation. An update is a standalone state-of-the-art for the topic — what someone with Parkinson's needs to know about where this approach stands today.
-
Levodopa increases substantia nigra iron: implications for Parkinson's disease
If levodopa actively increases nigral iron, iron-chelation strategies (e.g. deferiprone) become more compelling as adjunct therapy — not only to counteract disease-driven iron accumulation but potentially also drug-driven accumulation.